Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective

    People living with diabetes have many medical devices available to assist with disease management. A critical aspect that must be considered is how systems for continuous glucose monitoring and insulin pumps c...

    Johan Jendle, Peter Adolfsson, Pratik Choudhary, Klemen Dovc in Diabetologia (2024)

  2. No Access

    Article

    Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2023

    Dr. Stefan Pleus, Andrea Tytko, Rüdiger Landgraf, Lutz Heinemann in Die Diabetologie (2024)

  3. No Access

    Article

    Diagnose und Therapie des Typ-2-Diabetes im höheren Lebensalter

    Bundesweite Schätzungen der Diabetesprävalenz in Deutschland aus Erhebungen des Robert Koch-Instituts (RKI) ergaben 7,2 % (18- bis 79-Jährige), aus RKI-Telefonbefragungen 8,9 % (18-Jährige und Ältere) bzw. auf...

    Prof. Dr. Rüdiger Landgraf, Werner Scherbaum, Lutz Heinemann in Die Diabetologie (2023)

  4. Article

    Open Access

    Wearable based monitoring and self-supervised contrastive learning detect clinical complications during treatment of Hematologic malignancies

    Serious clinical complications (SCC; CTCAE grade ≥ 3) occur frequently in patients treated for hematological malignancies. Early diagnosis and treatment of SCC are essential to improve outcomes. Here we report...

    Malte Jacobsen, Rahil Gholamipoor, Till A. Dembek, Pauline Rottmann in npj Digital Medicine (2023)

  5. No Access

    Article

    Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022

    Prof. Dr. Rüdiger Landgraf, Lutz Heinemann, Erwin Schleicher in Die Diabetologie (2023)

  6. Article

    Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

    A technological solution for the management of diabetes in people who require intensive insulin therapy has been sought for decades. The last 10 years have seen substantial growth in devices that can be integr...

    Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming in Diabetologia (2023)

  7. Article

    Open Access

    Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus

    For decades, self-monitoring of blood glucose (SMBG) has been considered a cornerstone of adequate diabetes management. Structured SMBG can follow different monitoring patterns, and it results in improved glyc...

    Stefan Pleus, Guido Freckmann, Sebastian Schauer, Lutz Heinemann in Diabetes Therapy (2022)

  8. No Access

    Article

    Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021

    Prof. Dr. Erwin Schleicher, Christian Gerdes, Astrid Petersmann in Der Diabetologe (2022)

  9. No Access

    Article

    Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020

    Matthias Nauck, Christian Gerdes, Astrid Petersmann in Der Diabetologe (2021)

  10. Article

    Open Access

    Diabetes management intervention studies: lessons learned from two studies

    Several clinical studies investigated improvements of patient outcomes due to diabetes management interventions. However, chronic disease management is intricate with complex multifactorial behavior patterns. ...

    Bettina Petersen, Iris Vesper, Bernhild Pachwald, Nicole Dagenbach, Sina Buck in Trials (2021)

  11. No Access

    Article

    Definition, Klassifikation und Diagnostik des Diabetes mellitus

    Astrid Petersmann, Dirk Müller-Wieland, Ulrich A. Müller in Der Diabetologe (2020)

  12. Article

    Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

    Digital health technology, especially digital and health applications (‘apps’), have been develo** rapidly to help people manage their diabetes. Numerous health-related apps provided on smartphones and other...

    G. Alexander Fleming, John R. Petrie, Richard M. Bergenstal in Diabetologia (2020)

  13. Article

    Open Access

    Measurement Uncertainty Impacts Diagnosis of Diabetes Mellitus: Reliable Minimal Difference of Plasma Glucose Results

    The diagnosis of diabetes mellitus is based on suitable cut-off values of specific biomarkers, such as the concentration of glucose in plasma. The German Diabetes Association has very recently published a clin...

    Sandra Keutmann, Stephanie Zylla, Mathilde Dahl, Nele Friedrich in Diabetes Therapy (2020)

  14. Article

    Open Access

    Open source automated insulin delivery: addressing the challenge

    Do-it-yourself automated insulin delivery systems for people living with type 1 diabetes use commercially available continuous glucose sensors and insulin pumps linked by unregulated open source software. Upta...

    Nick Oliver, Monika Reddy, Claire Marriott, Tomas Walker in npj Digital Medicine (2019)

  15. No Access

    Article

    Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes

    Lutz Heinemann, Dorothee Deiss, Thorsten Siegmund, Sandra Schlüter in Der Diabetologe (2019)

  16. Article

    Improving the clinical value and utility of CGM systems: issues and recommendations

    The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many then believed CGM would revolutionise the use of intensive insulin therapy in diabetes; however, progress towa...

    John R. Petrie, Anne L. Peters, Richard M. Bergenstal, Reinhard W. Holl in Diabetologia (2017)

  17. Article

    Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

    Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes. However, even w...

    Lutz Heinemann, G. Alexander Fleming, John R. Petrie, Reinhard W. Holl in Diabetologia (2015)

  18. No Access

    Book

  19. No Access

    Article

    A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment

    We evaluated whether self-monitoring of blood glucose (SMBG) leads to better glycaemic control (HbA1c) in patients with type 2 diabetes on conventional insulin regimens.

    Michael A. Nauck, Burkhard Haastert, Christoph Trautner, Ulrich A. Müller in Diabetologia (2014)

  20. No Access

    Article

    A 4-h hyperglycaemic excursion induces rapid and slow changes in major electrolytes in blood in healthy human subjects

    Hyperglycaemia is well known to cause reductions in plasma Na+ levels or even hyponatraemia due to an osmotically induced dilution of the interstitium and blood. It is, however, unclear whether this dilution is s...

    Andreas Caduff, Lutz Heinemann, Mark S. Talary, Giacomo Di Benedetto in Acta Diabetologica (2012)

previous disabled Page of 2